Sean W Fanning

16PUBLICATIONS
78CO-AUTHORS
Biologically active moleculesBiodiscoveryMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 18, 2026
Allosteric Induction of Estrogen Receptor Ligand Binding Domain Tetramerization by a Distinct Complete Estrogen Receptor Antagonist.

Emma C Fink, Reena Chawla, Govinda R Hancock

|Aug 14, 2025
Benzestrol Isomer Stereochemistry Determines the Distinct Estrogenic Activities and Conformations of the Eight Isomers When Bound to Estrogen Receptor α.

Yingwei Hou, Jerome C Nwachukwu, Kathryn Carlson

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|Jun 04, 2025
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.

Yanyan Cai, Peihua Zhao, Fan Wu

|Feb 13, 2025
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC).

Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu

Pageof 3